http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014067986-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2be1effe2aad8610d58162b6e1f93fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0065
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
filingDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb8463a76b48dbfda475af976afb641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32b8bd8344be5b925bf6ecd6428e4920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5becabe894eba3cf0cd2fff073e696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d1f1b0d7f84a69da89fee8112fff532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059d7af44010227aa14e165e35de6d64
publicationDate 2016-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014067986-A8
titleOfInvention Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
abstract The present invention relates to a compound of the general formula (I) for pulmonary administration. The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Furthermore the present invention concerns a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject.
priorityDate 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3958
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID786492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424377

Total number of triples: 34.